Making Alzheimer’s Disease a National Priority: Has the National Alzheimer’s Project Act (NAPA) Fulfilled its Promise?

Thursday, 07/16/2020, 12:00 pm.   ARCHIVED EVENT

Location: webinar

In 2011, Congress passed the National Alzheimer’s Project Act (NAPA) calling for Alzheimer’s disease prevention, treatment, and care to be a priority for the United States and ordered creation of a National Plan to Address Alzheimer’s Disease which, among other goals, called for development of a cure or modifying treatment for Alzheimer’s disease by 2025.

This webinar will examine:

* NAPA’s goals and the progress made toward meeting them
* Whether Alzheimer’s disease is being appropriately prioritized in Washington
* Advancements in research and gaps in policy
* What, if any, changes need to be made in Washington to advance the path toward a cure


Senator Roy Blunt (R-MO)
Chair, Senate Appropriations Subcommittee on Labor, Health and Human Services and Education

Congressman John Garamendi (D-CA)
Member, Bipartisan Congressional Task Force on Alzheimer’s Disease

Mony J. de Leon, Ed.D.
Professor of Neuroscience in Radiology
Weill Cornell Medical College, Cornell University

Allison B. Reiss, MD
AFA Medical, Scientific and Memory Screening Advisory Board Member
Head, Inflammation Section, NYU Winthrop Research Institute


Hon. Steve Israel
Member, AFA Board of Directors
Director of the Institute of Politics and Global Affairs, Cornell University
Member of Congress (2001-2017)

Related Material:

Registration and Info